|Year : 2018 | Volume
| Issue : 1 | Page : 49-51
99m-Technetium sestamibi uptake in a gastric schwannoma
Mohamed Shawgi, Tamir Ali, Matthew Scott, George Petrides
Department of Radiology and Nuclear Medicine, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
|Date of Web Publication||5-Jan-2018|
Department of Radiology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP
| Abstract|| |
We report the case of a 74-year-old woman with primary hyperparathyroidism who underwent 99m-technetium-sestamibi single photon emission computed tomography-computed tomography for preoperative localization of parathyroid adenoma. Unexpected focal sestamibi uptake was observed at a 5 cm submucosal tumor arising from the greater curve of the stomach. The patient underwent partial gastrectomy and the histological and immunohistochemical findings were consistent with the diagnosis of gastric schwannoma.
Keywords: Gastric schwannoma, parathyroid, sestamibi, single photon emission computed tomography-computed tomography
|How to cite this article:|
Shawgi M, Ali T, Scott M, Petrides G. 99m-Technetium sestamibi uptake in a gastric schwannoma. World J Nucl Med 2018;17:49-51
|How to cite this URL:|
Shawgi M, Ali T, Scott M, Petrides G. 99m-Technetium sestamibi uptake in a gastric schwannoma. World J Nucl Med [serial online] 2018 [cited 2020 Jan 28];17:49-51. Available from: http://www.wjnm.org/text.asp?2018/17/1/49/222292
| Introduction|| |
Schwannomas are tumors that originate from Schwann cells of the nerve sheath. They rarely occur in the gastrointestinal tract with the most common site being the stomach. We present the rare case of a 74-year-old woman with gastric schwannoma presenting as an incidental finding on 99m-Technetium (99mTc)-sestamibi single photon emission computed tomography-computed tomography (SPECT/CT).
| Case Report|| |
A 74-year-old woman was referred by her family doctor to the endocrinology clinic with hypercalemia and elevated parathyroid hormone level. She complained of persistent fatigue and was under investigation for osteoporosis which had been unresponsive to treatment. She had no other significant co-morbidities and her physical examination was unremarkable.
Dual phase 99mTc-sestamibi parathyroid scintigraphy was performed for preoperative localization of parathyroid adenoma and showed focal radiotracer uptake at the lower pole of the left thyroid lobe on early and delayed phase imaging. SPECT/CT imaging confirmed the presence of a 6mm nodule that was inferior and posterior to the lower pole of the left thyroid lobe in keeping with a parathyroid adenoma [Figure 1].
|Figure 1: Coronal (a) and sagittal (b) delayed images of dual-phase 99m-technetium-sestamibi parathyroid scintigraphy showing persistent focal tracer uptake at the lower pole of the left thyroid lobe (arrows). Axial computed tomography (c), single photon emission computed tomography (d) and fused single photon emission computed tomography-computed tomography (e) images showing 6 mm nodule with high radiotracer uptake inferior and posterior to the lower pole of the left thyroid lobe (arrows), consistent with parathyroid adenoma|
Click here to view
Mild focal 99mTc-sestamibi uptake was unexpectedly observed in the upper abdomen. On the SPECT/CT images, the area of abnormal uptake corresponded to an incidental 5 cm smooth, exophytic mass centered on the greater curve of the body of the stomach that contained an ulcer on its mucosal side [Figure 2].
|Figure 2: Coronal fused single photon emission computed tomography-computed tomography (a) and axial computed tomography (b), single photon emission computed tomography (c) and fused single photon emission computed tomography-computed tomography (d) images showing mild tracer uptake in the upper abdomen within a rounded, smoothly marginated mass arising from the greater curve of the gastric body (arrow)|
Click here to view
The patient was reviewed by the upper gastrointestinal surgical team and underwent esophagoduodenoscopy and endoscopic ultrasound. Repeated biopsies of the mass were indeterminate. 18-fluorine fluorodeoxyglucose (18F-FDG) positron emission tomography-CT scan showed a significant 18-FDG uptake within the gastric mass and no abnormal tracer uptake elsewhere [Figure 3].
|Figure 3: Axial (a) and coronal (b) 18F- FDG PET/CT scan showing significant 18-FDG uptake within the gastric mass|
Click here to view
The patient underwent partial gastrectomy and the histological and immunohistochemical findings were consistent with the diagnosis of gastric schwannoma.
| Discussion|| |
99mTc-sestamibi is currently the radiotracer of choice for scintigraphic imaging of abnormal parathyroid glands. Hybrid SPECT/CT imaging allows acquisition of anatomical and functional information in a single imaging session with improved image quality and sensitivity compared to conventional planar scintigraphy. Sestamibi is a lipophilic cation that is distributed according to blood flow and concentrates intracellularly in the mitochondria, mainly within normal cardiac and thyroid cells. It accumulates within the mitochondria-rich oxyphil cells in parathyroid adenomas and hyperplastic parathyroid glands but is also taken up by a variety of benign and malignant neoplasms. False positive sestamibi uptake has been reported in thyroid, breast, lung and head and neck carcinomas and their lymph node and bony metastases, as well as bronchial carcinoids.,,,
Gastric schwannoma are generally benign, slow growing mesenchymal tumors that arise from the nerve plexus of the gut wall. They tend to occur in older adults (average age 58 years) and are more common in females. Most gastric schwannomas are asymptomatic tumors that are discovered incidentally, but in some cases, they can cause gastrointestinal bleeding, epigastric pain and palpable epigastric mass. The majority of tumors are reported to occur in the middle-third of the stomach along the lesser curvature and the typical endoscopic appearance is of a round, exophytic, submucosal mass with or without central ulceration. Preoperative diagnosis by endoscopy is challenging as its often difficult to differentiate gastric schwannoma from other submucosal tumors such as gastrointestinal stromal tumor. The mechanism of sestamibi uptake in mesenchymal tumors is unclear and to the best of our knowledge, there are no published case reports to date of sestamibi uptake in gastric schwannoma.
| Conclusion|| |
Sestamibi can accumulate in a wide range of benign and malignant tumors including gastric schwannoma. SPECT/CT provides accurate anatomical localization and improves diagnostic confidence.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986;57:2006-21.
Serra A, Bolasco P, Satta L, Nicolosi A, Uccheddu A, Piga M. Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients. Radiol Med 2006;111:999-1008.
Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996;37:1551-6.
Eslamy HK, Ziessman HA. Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc sestamibi SPECT and SPECT/CT. Radiographics 2008;28:1461-76.
Taillefer R, Robidoux A, Lambert R, Turpin S, Laperrière J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-65.
Yen TC, Tzen KY, Lee CM, Tsai CC. Squamous cell carcinoma of the lung mimicking an ectopic mediastinal parathyroid adenoma demonstrated by Tc-99m sestamibi in a hypercalcemic patient. Clin Nucl Med 1999;24:895-6.
Yapar Z, Kibar M, Sükan A, Paydas S, Zeren H, Inal M. Coincidental visualization of an atypical bronchial carcinoid on Tc-99m-sestamibi scan in Kallmann's syndrome. Ann Nucl Med 2002;16:61-5.
Glaser C, Pruckmayer M, Staudenherz A, Rasse M, Lang S, Leitha T. Utility of technetium-99m-sestamibi to assess osseous tumor spread. J Nucl Med 1996;37:1526-8.
Miettinen M, Blay JY, Sobin LH. Mesenchymal tumors of the stomach. In: Hamilton SR, Aaltonen LA, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000. p. 62-5.
Hou YY, Tan YS, Xu JF, Wang XN, Lu SH, Ji Y, et al.
Schwannoma of the gastrointestinal tract: A clinicopathological, immunohistochemical and ultrastructural study of 33 cases. Histopathology 2006;48:536-45.
Kwon MS, Lee SS, Ahn GH. Schwannomas of the gastrointestinal tract: Clinicopathological features of 12 cases including a case of esophageal tumor compared with those of gastrointestinal stromal tumors and leiomyomas of the gastrointestinal tract. Pathol Res Pract 2002;198:605-13.
[Figure 1], [Figure 2], [Figure 3]